Last reviewed · How we verify

NCT03417973: ACTIVE

Quality of Life and Pain Changes Due to DRG Stimulation for Chronic Pain

Terminated Last updated 19 March 2020
What this trial tests

trial testing dorsal root ganglion neuromodulation in Spinal; Nerve Root, Pain in 55 participants. Terminated before completion.

Timeline
1 August 2017
Primary endpoint
28 February 2019
31 March 2019

Quick facts

Lead sponsorKM Clinical Research Group
StatusTerminated
Study typeOBSERVATIONAL
Enrollment55
Start date1 August 2017
Primary completion28 February 2019
Estimated completion31 March 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

KM Clinical Research Group

Who can join

Adults 18 to 85, any sex, with Spinal; Nerve Root, Pain or Pelvic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

ACTIVE study- a prospective observational clinical study examining the changes in quality of life and pain following dorsal root ganglion stimulation for the treatment of chronic intractable pelvic and lower limb pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other KM Clinical Research Group trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03417973.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing